Selected research
Market Analysis & Forecast
Global Pathology Software Market Analysis and Forecast 2026-2032
Market perspective
The global Pathology Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Pathology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Pathology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Pathology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Pathology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Pathology Software include LBP, F. Q. Pathotech, CellsVision, Sectra, Digital Slide Archive, Aiforia, PathAI, Pathomation and Proscia, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pathology Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Pathology Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Pathology Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pathology Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pathology Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pathology Software revenue, projected growth trends, production technology, application and end-user industry.
Pathology Software Segment by Company
LBP
F. Q. Pathotech
CellsVision
Sectra
Digital Slide Archive
Aiforia
PathAI
Pathomation
Proscia
Indica Labs
Gestalt
Hologic
Dipath
iDeepWise
Pathology Software Segment by Type
LIS
IIMS
AI Separated
Pathology Software Segment by Application
Hospital
Diagnostic Centers
R&D Lab
Pathology Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pathology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathology Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pathology Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pathology Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pathology Software revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- LIS
- IIMS
- AI Separated
Applications
- Hospital
- Diagnostic Centers
- R&D Lab
Companies covered
- LBP
- F. Q. Pathotech
- CellsVision
- Sectra
- Digital Slide Archive
- Aiforia
- PathAI
- Pathomation
- Proscia
- Indica Labs
- Gestalt
- Hologic
- Dipath
- iDeepWise
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Pathology Software Market by Type
- 1.2.1 Global Pathology Software Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 LIS
- 1.2.3 IIMS
- 1.2.4 AI Separated
- 1.3 Pathology Software Market by Application
- 1.3.1 Global Pathology Software Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Diagnostic Centers
- 1.3.4 R&D Lab
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pathology Software Market Dynamics
- 2.1 Pathology Software Industry Trends
- 2.2 Pathology Software Industry Drivers
- 2.3 Pathology Software Industry Opportunities and Challenges
- 2.4 Pathology Software Industry Restraints
3 Global Growth Perspective
- 3.1 Global Pathology Software Market Perspective (2021-2032)
- 3.2 Global Pathology Software Growth Trends by Region
- 3.2.1 Global Pathology Software Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Pathology Software Market Size by Region (2021-2026)
- 3.2.3 Global Pathology Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Pathology Software Revenue by Players
- 4.1.1 Global Pathology Software Revenue by Players (2021-2026)
- 4.1.2 Global Pathology Software Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Pathology Software Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Pathology Software Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Pathology Software Key Players Headquarters & Area Served
- 4.4 Global Pathology Software Players, Product Type & Application
- 4.5 Global Pathology Software Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Pathology Software Market CR5 and HHI
- 4.6.3 2025 Pathology Software Tier 1, Tier 2, and Tier 3
5 Pathology Software Market Size by Type
- 5.1 Global Pathology Software Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Pathology Software Revenue by Type (2021-2032)
- 5.3 Global Pathology Software Revenue Market Share by Type (2021-2032)
6 Pathology Software Market Size by Application
- 6.1 Global Pathology Software Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Pathology Software Revenue by Application (2021-2032)
- 6.3 Global Pathology Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 LBP
- 7.1.1 LBP Company Information
- 7.1.2 LBP Business Overview
- 7.1.3 LBP Pathology Software Revenue and Gross Margin (2021-2026)
- 7.1.4 LBP Pathology Software Product Portfolio
- 7.1.5 LBP Recent Developments
- 7.2 F. Q. Pathotech
- 7.2.1 F. Q. Pathotech Company Information
- 7.2.2 F. Q. Pathotech Business Overview
- 7.2.3 F. Q. Pathotech Pathology Software Revenue and Gross Margin (2021-2026)
- 7.2.4 F. Q. Pathotech Pathology Software Product Portfolio
- 7.2.5 F. Q. Pathotech Recent Developments
- 7.3 CellsVision
- 7.3.1 CellsVision Company Information
- 7.3.2 CellsVision Business Overview
- 7.3.3 CellsVision Pathology Software Revenue and Gross Margin (2021-2026)
- 7.3.4 CellsVision Pathology Software Product Portfolio
- 7.3.5 CellsVision Recent Developments
- 7.4 Sectra
- 7.4.1 Sectra Company Information
- 7.4.2 Sectra Business Overview
- 7.4.3 Sectra Pathology Software Revenue and Gross Margin (2021-2026)
- 7.4.4 Sectra Pathology Software Product Portfolio
- 7.4.5 Sectra Recent Developments
- 7.5 Digital Slide Archive
- 7.5.1 Digital Slide Archive Company Information
- 7.5.2 Digital Slide Archive Business Overview
- 7.5.3 Digital Slide Archive Pathology Software Revenue and Gross Margin (2021-2026)
- 7.5.4 Digital Slide Archive Pathology Software Product Portfolio
- 7.5.5 Digital Slide Archive Recent Developments
- 7.6 Aiforia
- 7.6.1 Aiforia Company Information
- 7.6.2 Aiforia Business Overview
- 7.6.3 Aiforia Pathology Software Revenue and Gross Margin (2021-2026)
- 7.6.4 Aiforia Pathology Software Product Portfolio
- 7.6.5 Aiforia Recent Developments
- 7.7 PathAI
- 7.7.1 PathAI Company Information
- 7.7.2 PathAI Business Overview
- 7.7.3 PathAI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.7.4 PathAI Pathology Software Product Portfolio
- 7.7.5 PathAI Recent Developments
- 7.8 Pathomation
- 7.8.1 Pathomation Company Information
- 7.8.2 Pathomation Business Overview
- 7.8.3 Pathomation Pathology Software Revenue and Gross Margin (2021-2026)
- 7.8.4 Pathomation Pathology Software Product Portfolio
- 7.8.5 Pathomation Recent Developments
- 7.9 Proscia
- 7.9.1 Proscia Company Information
- 7.9.2 Proscia Business Overview
- 7.9.3 Proscia Pathology Software Revenue and Gross Margin (2021-2026)
- 7.9.4 Proscia Pathology Software Product Portfolio
- 7.9.5 Proscia Recent Developments
- 7.10 Indica Labs
- 7.10.1 Indica Labs Company Information
- 7.10.2 Indica Labs Business Overview
- 7.10.3 Indica Labs Pathology Software Revenue and Gross Margin (2021-2026)
- 7.10.4 Indica Labs Pathology Software Product Portfolio
- 7.10.5 Indica Labs Recent Developments
- 7.11 Gestalt
- 7.11.1 Gestalt Company Information
- 7.11.2 Gestalt Business Overview
- 7.11.3 Gestalt Pathology Software Revenue and Gross Margin (2021-2026)
- 7.11.4 Gestalt Pathology Software Product Portfolio
- 7.11.5 Gestalt Recent Developments
- 7.12 Hologic
- 7.12.1 Hologic Company Information
- 7.12.2 Hologic Business Overview
- 7.12.3 Hologic Pathology Software Revenue and Gross Margin (2021-2026)
- 7.12.4 Hologic Pathology Software Product Portfolio
- 7.12.5 Hologic Recent Developments
- 7.13 Dipath
- 7.13.1 Dipath Company Information
- 7.13.2 Dipath Business Overview
- 7.13.3 Dipath Pathology Software Revenue and Gross Margin (2021-2026)
- 7.13.4 Dipath Pathology Software Product Portfolio
- 7.13.5 Dipath Recent Developments
- 7.14 iDeepWise
- 7.14.1 iDeepWise Company Information
- 7.14.2 iDeepWise Business Overview
- 7.14.3 iDeepWise Pathology Software Revenue and Gross Margin (2021-2026)
- 7.14.4 iDeepWise Pathology Software Product Portfolio
- 7.14.5 iDeepWise Recent Developments
8 North America
- 8.1 North America Pathology Software Revenue (2021-2032)
- 8.2 North America Pathology Software Revenue by Type (2021-2032)
- 8.2.1 North America Pathology Software Revenue by Type (2021-2026)
- 8.2.2 North America Pathology Software Revenue by Type (2027-2032)
- 8.3 North America Pathology Software Revenue Share by Type (2021-2032)
- 8.4 North America Pathology Software Revenue by Application (2021-2032)
- 8.4.1 North America Pathology Software Revenue by Application (2021-2026)
- 8.4.2 North America Pathology Software Revenue by Application (2027-2032)
- 8.5 North America Pathology Software Revenue Share by Application (2021-2032)
- 8.6 North America Pathology Software Revenue by Country
- 8.6.1 North America Pathology Software Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Pathology Software Revenue by Country (2021-2026)
- 8.6.3 North America Pathology Software Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Pathology Software Revenue (2021-2032)
- 9.2 Europe Pathology Software Revenue by Type (2021-2032)
- 9.2.1 Europe Pathology Software Revenue by Type (2021-2026)
- 9.2.2 Europe Pathology Software Revenue by Type (2027-2032)
- 9.3 Europe Pathology Software Revenue Share by Type (2021-2032)
- 9.4 Europe Pathology Software Revenue by Application (2021-2032)
- 9.4.1 Europe Pathology Software Revenue by Application (2021-2026)
- 9.4.2 Europe Pathology Software Revenue by Application (2027-2032)
- 9.5 Europe Pathology Software Revenue Share by Application (2021-2032)
- 9.6 Europe Pathology Software Revenue by Country
- 9.6.1 Europe Pathology Software Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Pathology Software Revenue by Country (2021-2026)
- 9.6.3 Europe Pathology Software Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Pathology Software Revenue (2021-2032)
- 10.2 China Pathology Software Revenue by Type (2021-2032)
- 10.2.1 China Pathology Software Revenue by Type (2021-2026)
- 10.2.2 China Pathology Software Revenue by Type (2027-2032)
- 10.3 China Pathology Software Revenue Share by Type (2021-2032)
- 10.4 China Pathology Software Revenue by Application (2021-2032)
- 10.4.1 China Pathology Software Revenue by Application (2021-2026)
- 10.4.2 China Pathology Software Revenue by Application (2027-2032)
- 10.5 China Pathology Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Pathology Software Revenue (2021-2032)
- 11.2 Asia Pathology Software Revenue by Type (2021-2032)
- 11.2.1 Asia Pathology Software Revenue by Type (2021-2026)
- 11.2.2 Asia Pathology Software Revenue by Type (2027-2032)
- 11.3 Asia Pathology Software Revenue Share by Type (2021-2032)
- 11.4 Asia Pathology Software Revenue by Application (2021-2032)
- 11.4.1 Asia Pathology Software Revenue by Application (2021-2026)
- 11.4.2 Asia Pathology Software Revenue by Application (2027-2032)
- 11.5 Asia Pathology Software Revenue Share by Application (2021-2032)
- 11.6 Asia Pathology Software Revenue by Country
- 11.6.1 Asia Pathology Software Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Pathology Software Revenue by Country (2021-2026)
- 11.6.3 Asia Pathology Software Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Pathology Software Revenue (2021-2032)
- 12.2 SAMEA Pathology Software Revenue by Type (2021-2032)
- 12.2.1 SAMEA Pathology Software Revenue by Type (2021-2026)
- 12.2.2 SAMEA Pathology Software Revenue by Type (2027-2032)
- 12.3 SAMEA Pathology Software Revenue Share by Type (2021-2032)
- 12.4 SAMEA Pathology Software Revenue by Application (2021-2032)
- 12.4.1 SAMEA Pathology Software Revenue by Application (2021-2026)
- 12.4.2 SAMEA Pathology Software Revenue by Application (2027-2032)
- 12.5 SAMEA Pathology Software Revenue Share by Application (2021-2032)
- 12.6 SAMEA Pathology Software Revenue by Country
- 12.6.1 SAMEA Pathology Software Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Pathology Software Revenue by Country (2021-2026)
- 12.6.3 SAMEA Pathology Software Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst